Immunogen Inc (DELISTED) (IMGN:DL)
31.25
USD |
NASDAQ |
Feb 09, 16:00
Immunogen Profit Margin (Quarterly): 27.11% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AbbVie, Inc. | 1.13% |
| Pfizer Inc. | 21.32% |
| Johnson & Johnson | 21.47% |
| Merck & Co., Inc. | 33.68% |
| Cerevel Therapeutics Holdings Inc (DELISTED) | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -24.37% |
| Return on Assets | -14.52% |
| Return on Invested Capital | -22.25% |
| Gross Profit Margin (Quarterly) | 98.10% |
| Operating Margin (Quarterly) | 22.88% |
| Return on Net Operating Assets | -105.4% |